Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Jan 15;265(2):327–336. doi: 10.1042/bj2650327

The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

V J Bom 1, R M Bertina 1
PMCID: PMC1136891  PMID: 2302175

Abstract

In the extrinsic pathway of blood coagulation, Factor X is activated by a complex of tissue factor, factor VII(a) and Ca2+ ions. Using purified human coagulation factors and a sensitive spectrophotometric assay for Factor Xa, we could demonstrate activation of Factor X by Factor VIIa in the absence of tissue-factor apoprotein, phospholipids and Ca2+. This finding allowed a kinetic analysis of the contribution of each of the cofactors. Ca2+ stimulated the reaction rate 10-fold at an optimum of 6 mM (Vmax. of 1.1 x 10(-3) min-1) mainly by decreasing the Km of Factor X (to 11.4 microM). In the presence of Ca2+, 25 microM-phospholipid caused a 150-fold decrease of the apparent Km and a 2-fold increase of the apparent Vmax. of the reaction; however, both kinetic parameters increased with increasing phospholipid concentration. Tissue-factor apoprotein contributed to the reaction rate mainly by an increase of the Vmax., in both the presence (40,500-fold) and absence (4900-fold) of phospholipid. The formation of a ternary complex of Factor VIIa with tissue-factor apoprotein and phospholipid was responsible for a 15 million-fold increase in the catalytic efficiency of Factor X activation. The presence of Ca2+ was absolutely required for the stimulatory effects of phospholipid and apoprotein. The data fit a general model in which the Ca2(+)-dependent conformation allows Factor VIIa to bind tissue-factor apoprotein and/or a negatively charged phospholipid surface resulting into a decreased intrinsic Km and an increased Vmax. for the activation of fluid-phase Factor X.

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach R., Gentry R., Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry. 1986 Jul 15;25(14):4007–4020. doi: 10.1021/bi00362a005. [DOI] [PubMed] [Google Scholar]
  2. Bach R., Nemerson Y., Konigsberg W. Purification and characterization of bovine tissue factor. J Biol Chem. 1981 Aug 25;256(16):8324–8331. [PubMed] [Google Scholar]
  3. Bach R., Oberdick J., Nemerson Y. Immunoaffinity purification of bovine factor VII. Blood. 1984 Feb;63(2):393–398. [PubMed] [Google Scholar]
  4. Bajaj S. P., Rapaport S. I., Brown S. F. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem. 1981 Jan 10;256(1):253–259. [PubMed] [Google Scholar]
  5. Bajaj S. P., Rapaport S. I., Russell W. A. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX. Biochemistry. 1983 Aug 16;22(17):4047–4053. doi: 10.1021/bi00286a009. [DOI] [PubMed] [Google Scholar]
  6. Bom V. J., Ram I. E., Alderkamp G. H., Reinalda-Poot H. H., Bertina R. M. Application of factor VII-Sepharose affinity chromatography in the purification of human tissue factor apoprotein. Thromb Res. 1986 Jun 1;42(5):635–643. doi: 10.1016/0049-3848(86)90342-7. [DOI] [PubMed] [Google Scholar]
  7. Bom V. J., van Tilburg N. H., Krommenhoek-van Es C., Bertina R. M. Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformation. Thromb Haemost. 1986 Dec 15;56(3):343–348. [PubMed] [Google Scholar]
  8. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  9. Broze G. J., Jr Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982 Sep;70(3):526–535. doi: 10.1172/JCI110644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Broze G. J., Jr, Leykam J. E., Schwartz B. D., Miletich J. P. Purification of human brain tissue factor. J Biol Chem. 1985 Sep 15;260(20):10917–10920. [PubMed] [Google Scholar]
  11. Broze G. J., Jr, Majerus P. W. Purification and properties of human coagulation factor VII. J Biol Chem. 1980 Feb 25;255(4):1242–1247. [PubMed] [Google Scholar]
  12. Di Scipio R. G., Hermodson M. A., Yates S. G., Davie E. W. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977 Feb 22;16(4):698–706. doi: 10.1021/bi00623a022. [DOI] [PubMed] [Google Scholar]
  13. Esmon N. L., Owen W. G., Esmon C. T. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 1982 Jan 25;257(2):859–864. [PubMed] [Google Scholar]
  14. Forman S. D., Nemerson Y. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4675–4679. doi: 10.1073/pnas.83.13.4675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Freyssinet J. M., Gauchy J., Cazenave J. P. The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. Biochem J. 1986 Aug 15;238(1):151–157. doi: 10.1042/bj2380151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guha A., Bach R., Konigsberg W., Nemerson Y. Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles. Proc Natl Acad Sci U S A. 1986 Jan;83(2):299–302. doi: 10.1073/pnas.83.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hagen F. S., Gray C. L., O'Hara P., Grant F. J., Saari G. C., Woodbury R. G., Hart C. E., Insley M., Kisiel W., Kurachi K. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2412–2416. doi: 10.1073/pnas.83.8.2412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Holloway P. W. A simple procedure for removal of Triton X-100 from protein samples. Anal Biochem. 1973 May;53(1):304–308. doi: 10.1016/0003-2697(73)90436-3. [DOI] [PubMed] [Google Scholar]
  19. Hultin M. B., Nemerson Y. Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIII. Blood. 1978 Nov;52(5):928–940. [PubMed] [Google Scholar]
  20. Jackson C. M. Factor X. Prog Hemost Thromb. 1984;7:55–109. [PubMed] [Google Scholar]
  21. Jesty J., Morrison S. A. The activation of Factor IX by tissue factor-Factor VII in a bovine plasma system lacking Factor X. Thromb Res. 1983 Oct 15;32(2):171–181. doi: 10.1016/0049-3848(83)90028-2. [DOI] [PubMed] [Google Scholar]
  22. Jesty J., Silverberg S. A. Kinetics of the tissue factor-dependent activation of coagulation Factors IX and X in a bovine plasma system. J Biol Chem. 1979 Dec 25;254(24):12337–12345. [PubMed] [Google Scholar]
  23. Jobin F., Esnouf M. P. Studies on the formation of the prothrombin-converting complex. Biochem J. 1967 Mar;102(3):666–674. doi: 10.1042/bj1020666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Keyt B., Furie B. C., Furie B. Structural transitions in bovine factor X associated with metal binding and zymogen activation. Studies using conformation-specific antibodies. J Biol Chem. 1982 Aug 10;257(15):8687–8695. [PubMed] [Google Scholar]
  25. Leytus S. P., Chung D. W., Kisiel W., Kurachi K., Davie E. W. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3699–3702. doi: 10.1073/pnas.81.12.3699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mertens K., Bertina R. M. Pathways in the activation of human coagulation factor X. Biochem J. 1980 Mar 1;185(3):647–658. doi: 10.1042/bj1850647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mertens K., Bertina R. M. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Biochem J. 1984 Nov 1;223(3):607–615. doi: 10.1042/bj2230607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mertens K., Cupers R., Van Wijngaarden A., Bertina R. M. Binding of human blood-coagulation Factors IXa and X to phospholipid membranes. Biochem J. 1984 Nov 1;223(3):599–605. doi: 10.1042/bj2230599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mertens K., van Wijngaarden A., Bertina R. M. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX. Thromb Haemost. 1985 Oct 30;54(3):654–660. [PubMed] [Google Scholar]
  30. Morrison S. A., Jesty J. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood. 1984 Jun;63(6):1338–1347. [PubMed] [Google Scholar]
  31. Nelsestuen G. L., Broderius M., Martin G. Role of gamma-carboxyglutamic acid. Cation specificity of prothrombin and factor X-phospholipid binding. J Biol Chem. 1976 Nov 25;251(22):6886–6893. [PubMed] [Google Scholar]
  32. Nelsestuen G. L. Interactions of vitamin K-dependent proteins with calcium ions and phospholipid membranes. Fed Proc. 1978 Oct;37(12):2621–2625. [PubMed] [Google Scholar]
  33. Nelsestuen G. L., Kisiel W., Di Scipio R. G. Interaction of vitamin K dependent proteins with membranes. Biochemistry. 1978 May 30;17(11):2134–2138. doi: 10.1021/bi00604a017. [DOI] [PubMed] [Google Scholar]
  34. Nemerson Y., Bach R. Tissue factor revisited. Prog Hemost Thromb. 1982;6:237–261. [PubMed] [Google Scholar]
  35. Nemerson Y., Gentry R. An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. Biochemistry. 1986 Jul 15;25(14):4020–4033. doi: 10.1021/bi00362a006. [DOI] [PubMed] [Google Scholar]
  36. Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry. 1966 Feb;5(2):601–608. doi: 10.1021/bi00866a029. [DOI] [PubMed] [Google Scholar]
  37. Nesheim M. E., Taswell J. B., Mann K. G. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem. 1979 Nov 10;254(21):10952–10962. [PubMed] [Google Scholar]
  38. Nesheim M. E., Tracy R. P., Mann K. G. "Clotspeed," a mathematical simulation of the functional properties of prothrombinase. J Biol Chem. 1984 Feb 10;259(3):1447–1453. [PubMed] [Google Scholar]
  39. Osterud B., Berre A., Otnaess A. B., Bjorklid E., Prydz H. Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry. 1972 Jul 18;11(15):2853–2857. doi: 10.1021/bi00765a018. [DOI] [PubMed] [Google Scholar]
  40. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pusey M. L., Nelsestuen G. L. The physical significance of Km in the prothrombinase reaction. Biochem Biophys Res Commun. 1983 Jul 29;114(2):526–532. doi: 10.1016/0006-291x(83)90812-4. [DOI] [PubMed] [Google Scholar]
  42. Radcliffe R., Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975 Jan 25;250(2):388–395. [PubMed] [Google Scholar]
  43. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980 Jan 10;255(1):274–283. [PubMed] [Google Scholar]
  44. Shapiro S. S., Waugh D. F. The purification of human prothrombin. Thromb Diath Haemorrh. 1966 Dec 1;16(3):468–490. [PubMed] [Google Scholar]
  45. Silverberg S. A., Nemerson Y., Zur M. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. J Biol Chem. 1977 Dec 10;252(23):8481–8488. [PubMed] [Google Scholar]
  46. Tanaka H., Janssen B., Preissner K. T., Müller-Berghaus G. Purification of glycosylated apoprotein of tissue factor from human brain and inhibition of its procoagulant activity by a specific antibody. Thromb Res. 1985 Dec 15;40(6):745–756. doi: 10.1016/0049-3848(85)90312-3. [DOI] [PubMed] [Google Scholar]
  47. Tankersley D. L., Alving B. M., Finlayson J. S. Preparation of beta-XIIa (Hageman factor fragment) from human plasma. Thromb Res. 1982 Feb 15;25(4):307–317. doi: 10.1016/0049-3848(82)90231-6. [DOI] [PubMed] [Google Scholar]
  48. Walker F. J. Protein S and the regulation of activated protein C. Semin Thromb Hemost. 1984 Apr;10(2):131–138. doi: 10.1055/s-2007-1004415. [DOI] [PubMed] [Google Scholar]
  49. Warn-Cramer B. J., Bajaj S. P. Intrinsic versus extrinsic coagulation. Kinetic considerations. Biochem J. 1986 Nov 1;239(3):757–762. doi: 10.1042/bj2390757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  51. Zur M., Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem. 1980 Jun 25;255(12):5703–5707. [PubMed] [Google Scholar]
  52. Zur M., Nemerson Y. The esterase activity of coagulation factor VII. Evidence for intrinsic activity of the zymogen. J Biol Chem. 1978 Apr 10;253(7):2203–2209. [PubMed] [Google Scholar]
  53. van Dieijen G., Tans G., Rosing J., Hemker H. C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem. 1981 Apr 10;256(7):3433–3442. [PubMed] [Google Scholar]
  54. van Rijn J. L., Govers-Riemslag J. W., Zwaal R. F., Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry. 1984 Sep 25;23(20):4557–4564. doi: 10.1021/bi00315a008. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES